Clinical Trial Update: Bioequivalence Study of Generic Tretinoin 0.1% Microsphere Gel, 0.1% Retin-A Micro® and Placebo [Phase 3]

View source ↗

Summary

Phase 3 bioequivalence trial comparing generic tretinoin 0.1% microsphere gel to branded Retin-A Micro and placebo in acne. Results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne

Drugs mentioned

• Generic tretinoin 0.1% microsphere gel (tretinoin)
• RETIN-A MICRO (TRETINOIN)

Snippet

Sponsor: Spear Pharmaceuticals | Conditions: Acne | Phase 3 | Status: COMPLETED | Results posted: 2014-10-16